Higher incidence rates have been found for some AI/ AN than NHW populations in the same geographic areas and for males as compared with females. However, previous studies have been hampered by lack of data in individual anatomic cancer sites, misclassification of AI/AN individuals, and small numbers of cases.
The purpose of this study is to improve the characterization of incidence of cancers of the oral cavity and pharynx in the AI/AN population, relative to the NHW population, by using techniques to minimize the effect of race misclassification in cancer surveillance data. This study further examines incidence rates of individual anatomic cancer sites in the oral cancer and pharynx group and stratifies findings by Indian Health Service (IHS) region.
MATERIALS AND METHODS
Detailed descriptions of the data sources and methods used for this analysis are found in another paper in this supplement. 4 
Cancer Cases
Population-based central cancer registries collect information on all new cancer cases within their geographic boundaries. They participate in the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI), the National Program for Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC), or both. 1, 5 Primary cancer site and histology data are coded according to the International Classification of Diseases for Oncology (ICD-O) edition in use at the time of diagnosis and converted to the Third Edition. 6 Ten anatomic sites of cancers of the oral cavity and pharynx were defined with the following ICD-O codes: lip (C00.0-C00.9), tongue (C01.9-C02.9), gum and other mouth (C03.0-C03.9, C05.0-C06.9), floor of the mouth (C04.0-C04.9), salivary gland (C07.9-C08.9), oropharynx (C10.0-C10.9), tonsil (C09.0-C09.9), nasopharynx (C11.0-C11.9), hypopharynx (C12.9-C13.9), and other (C14.0, C14.2-C14. 8) . Kaposi sarcomas at these sites were excluded, as were histology codes 9590 to 9989, 9050 to 9055, and 9140. All cases of oral cavity and pharynx cancers included in this study were ascertained by population-based cancer registries that agreed to participate and met the United States Cancer Statistics standards for high-quality data within states 5 ; the states that met quality criteria are listed in the footnotes of Table 1 .
Coding race for AI/AN cancer cases combines information from data linkages with the IHS patient registration database and the multiple race fields in central cancer registry records. 7 The IHS provides medical services to AI/AN persons who are members of federally recognized tribes. To reduce the misclassification of AI/AN race, central cancer registries worked with the IHS to link all case records with the IHS patient registration database to identify AI/AN cases misclassified as non-Native. Linkages were conducted using LinkPlus, a probabilistic linkage software program developed by CDC. 8 The information from the linkages was then combined with the multiple race fields coded in cancer registry records. Further details about linkages and coding rules for multiple races are described elsewhere in this Supplement. 4 To further improve race classification, analyses focused on Contract Health Service Delivery Area (CHSDA) counties ( Fig. 1) , which generally contain federally recognized tribal lands or are adjacent to tribal lands. The proportions of AI/AN in relation to total population are higher in CHSDA counties than in non-CHSDA counties, and previous analyses indicate less race misclassification for AI/AN in these counties. 9 About 56% of the US AI/AN population reside in CHSDA counties. This proportion varies by IHS region: Alaska 5 100%; East 5 13.1%; Northern Plains 5 59.0%; Southern Plains 5 64.1%; Pacific Coast 5 55.6%; Southwest 5 87.5%. In addition, incidence rates were stratified by IHS regions (Alaska, Pacific Coast, Northern Plains, Southern Plains, Southwest, and East) to evaluate the geographic variation of cancer incidence in the AI/AN population ( Fig. 1) . Additional details about CHSDA counties and IHS are provided elsewhere. 4 Cancer stage data for this report spanned changes in SEER summary stage coding. 
Population Estimates
In the 2000 census, the US Census Bureau for the first time allowed respondents to identify themselves in 1 or more race fields. 7 To facilitate comparison with population estimates based on a single race field before 2000, the CDC's National Center for Health Statistics, in collaboration with the Census Bureau, developed a technique of bridging race categories into single-race annual population estimates. 12 The NCI makes further refinements to these estimates regarding race and county geographic codes; these estimates were used as denominators in this report. 13 
Statistical Analyses
Cancer incidence rates are expressed per 100,000 persons and are age-adjusted by 19 age groups to the 2000 US standard population. Rates and 95% modified gamma confidence intervals (CI) are generated using SEER*Stat Software. 14, 15 Percent distributions (stage of disease at diagnosis and data on individual anatomic sites) are also age-adjusted. For presentation, counts are suppressed when the category contains 5 or fewer cases. Groupings for age-specific analyses were selected based on the distribution for all oral cavity and pharyngeal cancer cases combined. Rate ratios (RRs)-the age-adjusted incidence rate among AI/AN divided by the age-adjusted incidence rate among NHW-and 95% CI were calculated to facilitate regional comparisons of incidence rates between AI/AN and NHW populations.
RESULTS
AI/AN incidence rates for all cancers of the oral cavity and pharynx combined showed substantial regional variation compared with NHW (Table 1) . Furthermore incidence rates for all US counties in the dataset were generally lower than those in CHSDA counties where race misclassification is lower. Therefore, subsequent results and discussion are limited to CHSDA counties unless otherwise noted. Over all regions, NHW had a higher incidence rate for cancers of the oral cavity and pharynx (11.0) than did AI/AN (8.5). Among AI/AN, incidence rates for both sexes and all oral cavity and pharynx cancers combined ranged from 3.3 in the Southwest to 16.3 in Alaska. Rates did not vary substantially in the IHS regions among the NHW population. Incidence rates were generally higher for males than females among both AI/AN (male:female rate ratio [RR] 2.7) and NHW (male:female RR, 2.6) for all areas combined. However, there is much more geographic variation in the male:female RR for for AI/AN (from 1.7 in Alaska to 3.2 in the Pacific Coast) than for NHW (range 2.5 to 3.1).
The incidence RRs for AI/AN to NHW varied across IHS regions, with AI/AN having significantly higher incidence rates in the Northern Plains and Alaska for both sexes combined, for males in the Northern Plains, and for females in Alaska. In the Southern Plains AI/AN and NHW incidence rates are comparable. For other regions and for all regions combined AI/AN incidence rates are lower than NHW rates, reaching significance in each region, for males, females, and both sexes combined except in the East.
Incidence rates, counts, percent distributions, and RRs for individual anatomic sites of oral cavity and pharynx cancers in the 6 IHS regions and for all regions combined for CHSDA counties are shown in Table 2 . For all regions combined, AI/AN have a significantly lower incidence rate of cancer of the tongue (1.6) than NHW (2.9), whereas AI/AN have a significantly higher rate of nasopharyngeal cancer (1.1) than NHW (0.4). Rates for other anatomic sites are generally modestly lower in AI/AN populations for all regions combined, reaching significance for cancer of the lip, gum and other mouth, floor of mouth, salivary gland, and oropharynx. When analyzed by region, significantly higher AI/AN incidence rates of nasopharyngeal cancer compared with NHW are noted in Alaska (RR, 8.82), the Southern Plains (RR, 2.03), and the Pacific Coast (RR, 2.14). AI/AN incidence rates are significantly higher than NHW rates for tonsillar cancer in the Northern Plains (RR, 1.74) and for cancer of the floor of the mouth in Alaska (RR, 3.12). The incidence rate for cancer of the tongue is similar among AI/AN and NHW in Alaska and the Northern Plains and generally lower for AI/AN than NHW elsewhere, with significance reached in the Southwest and Pacific Coast. Other oral cavity and pharynx cancers are generally diagnosed less frequently among AI/AN than NHW.
The age at diagnosis for oral cavity and pharynx cancers is lower for AI/AN than for NHW, with 36.3% of cases in AI/AN diagnosed at age 65 years or older as compared with 48.8% of cases among NHW (Table  3 ). This pattern holds true for all regions of the country except for Alaska, where the percentage of cases diagnosed at age 65 years or older is 39.4% for AI/AN and 35.7% for NHW. In general, the pattern of younger age at diagnosis among AI/AN than NHW 
DISCUSSION
The incidence rate for all cancers of the oral cavity and pharynx combined among AI/AN in CHSDA counties in the US is lower than among NHW (8.5 vs 11.0). However, detailed analyses by individual anatomic cancer sites and/or by IHS geographic regions show a much more varied picture. In particular, cancers of the tongue make up a smaller, whereas nasopharyngeal cancers make up a much larger, proportion of these cancers in AI/AN than NHW. In Alaska, the incidence rates for all cancers of the oral cavity and pharynx is significantly higher for AI/AN than for NHW (RR, 1.53). In addition, nasopharyngeal cancer stands out as having significantly higher incidence rates among AI/AN than NHW in Alaska, the Southern Plains, and the Pacific Coast. Nasopharyngeal cancers comprise 42% of all Alaskan AI/AN cancers of the oral cavity and pharynx. Other instances of significantly higher incidence rates Counts less than 6 are suppressed; if no cases were reported, then rates and age-adjusted percentage distributions could not be calculated.
among AI/AN than NHW in the same geographic region are indicated above. It is important to take differences revealed in the detailed analyses into account when describing the burden of cancer and in cancer control planning. The age at diagnosis for all cancers of the oral cavity and pharynx was found to be lower for AI/AN than for NHW. Tobacco use is by far the greatest risk factor for oral cavity and pharynx cancers. [16] [17] [18] AI/AN are more likely to be current smokers (31.1%) than NHW (22.8%), as reported by the Behavioral Risk Factor Surveillance Surveys (BRFSS) for years 2000 to 2006. 19 High rates of oral cavity and pharynx cancers among AI/AN correspond with high smoking prevalence estimates with 1 exception. Smoking prevalence in the East (36.5%) is high; however, the overall rate of oral cavity and pharynx cancer is among the lowest (7.5 per 100,000). However, the East (Fig. 1) has a low percentage of CHSDA counties, which may affect external validity of cancer incidence data. In the Southwest, where the prevalence of current smoking is low (21.1%), 19 cancer rates for oral cavity and pharynx are also low (3.3 per 100,000). Oral cavity and pharynx cancers are up to 5 times more common in drinkers than nondrinkers. 17, 20 Alcohol strongly increases a smoker's risk of cancer of the oral cavity and pharynx, possibly by increasing the exposure to carcinogens. [21] [22] [23] BRFSS 2000 to 2006 19 data indicate a similar pattern across IHS regions of self-reported heavy drinking among AI/AN groups (range, 3%-7%) and NHW (6%).
Other major risk factors for oral cavity and pharynx cancers include a diet low in fruits and vegetables and, for some anatomic sites, viral infection. 17, 24 AI/AN and NHW persons reported to BRFSS a similar prevalence of consuming 5 or more servings of fruits and vegetables per day with little variation by IHS region. 19 Risk factors also vary for individual anatomic sites. Exposures to sunlight, outdoor occupation, and rural residence have been identified as risk factors for lip cancer. Human papilloma virus has been associated with cancers of the tonsil, base of the tongue, and oropharynx. 25, 26 The incidence patterns of oral cavity and pharyngeal cancers observed in the present study may reflect racial/ethnic and regional differences in exposure to these and other factors.
Epstein-Barr virus (EBV) is almost always found in nasopharyngeal cancer cells. 27 Infection with EBV alone is not sufficient to cause nasopharyngeal cancer. In studies primarily of Asian populations, nasopharyngeal cancer has been found to be associated with consumption of a variety of preserved foods beginning at an early age. 28 Occupation exposures to formaldehyde, wood dust, and wood preservatives may increase risk for nasopharyngeal cancer. 29, 30 This study shows that Alaska Native people have uniquely increased risk compared with other AI/AN populations in the United States. EBV has been confirmed present in nasopharyngeal cancer tissues among Alaska Natives, 31 but the role of genetic, environmental, and diet factors in AI/AN persons in Alaska has not been identified.
The presentation of incidence rates for individual anatomic sites for cancers of the oral cavity and pharynx for the 6 IHS regions is possible because of the matching of NPCR and SEER data with the IHS health database, thereby enhancing classification of AI/AN individuals. Limitations of this linkage include exclusion of AI/AN cases from areas with little or no provision of IHS medical services, including many urban areas. Also, some individuals who are AI/AN may access healthcare from other sources. In general, AI/AN are much more accurately classified in CHSDA counties than in non-CHSDA counties. For this reason, CHSDA counties form the basis of most analyses performed here. The availability of more detailed data on oral cavity and pharynx cancers in AI/AN populations will provide a better estimation of the burden of cancer, allow a more targeted allocation of cancer control resources, and facilitate further examination of trends in incidence as well as analysis of survival, morbidity, and mortality.
